New Patient-Friendly Resource on Prescription Opioids Available

Jun 07, 2016 - 08:13 AM

The 黑料正能量 Association (AHA) and the Centers for Disease Control and Prevention (CDC) today issued a new patient-friendly resource on prescription opioids. 

鈥淓very day, hospitals see how misuse of and overdose from prescription opioids affects patients鈥 families, loved ones and communities,鈥 said AHA President and CEO Rick Pollack. 鈥淲e want patients to have open, honest conversations with their care providers about the best way to manage pain. The goal is to help patients manage their pain and continue to lead healthy, productive lives. We are pleased to work with the CDC to develop and share this new resource with hospitals and care providers across the country.鈥

Patients and consumers can use the resource to talk to their physicians about the risks and benefits of prescription opioids, how to use these medications as safely and effectively as possible, and ways to manage pain that do not involve prescription opioids.

The new patient resource is available on  and AHA.org. For more information on how the AHA and CDC are addressing the opioid abuse crisis: 

Related News Articles

Headline
FDA announces recall for certain IV bags
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride鈥
Headline
Recall issued for aspiration system by Q鈥橝pel Medical
The Food and Drug Administration has identified a Class I recall of Q鈥橝pel Medical 072 Aspiration System after the company submitted three device event reports鈥
Headline
Whooping cough cases surpass 8,000 nationwide
There have been 8,064 reported cases of whooping cough in the U.S. so far this year, according to the latest data from the Centers for Disease Control and鈥
Headline
Study finds increase in drug-resistant A. baumannii infections
A study published April 17 by BMC Infectious Diseases found increased incidents of Acinetobacter baumannii and carbapenem-resistant A. baumannii infections鈥
Headline
FDA issues alerts on certain catheters produced by BD, Conavi
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue鈥
Headline
Study finds increase of invasive strep infections
The incidence of invasive group A strep infections increased from 3.6 to 8.2 cases per 100,000 people from 2013 to 2022, according to a study authored by the鈥